Standout Papers

Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of H... 1999 2026 2008 2017 2.5k
  1. Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol (1999)
    Hanna E. Bloomfield, Sander J. Robins et al. New England Journal of Medicine

Immediate Impact

4 by Nobel laureates 5 from Science/Nature 98 standout
Sub-graph 1 of 14

Citing Papers

The changing landscape of atherosclerosis
2021 StandoutNature
Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks
2020 StandoutNobel
66 intermediate papers

Works of Marshall B. Elam being referenced

Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study
2018
Increased hepatic VLDL secretion, lipogenesis, and SREBP-1 expression in the corpulent JCR:LA-cp rat
2001
and 9 more

Author Peers

Author Last Decade Papers Cites
Marshall B. Elam 3619 3194 1991 82 7.1k
Moti L. Kashyap 4055 4377 1510 160 8.2k
Eran Leitersdorf 5098 2495 2736 151 8.7k
Gérald Luc 3067 2544 1763 87 8.9k
D. J. Betteridge 3442 4158 1552 141 9.6k
David W. Bilheimer 4618 2229 1922 61 7.4k
Jiří Fröhlich 4586 3644 1312 160 9.8k
Marcello Arca 2860 2032 1291 216 6.2k
Jan Albert Kuivenhoven 5854 4324 2153 155 10.3k
Pekka Koskinen 3568 3416 863 69 7.4k
Y. Antero Kesäniemi 3639 3612 1859 184 9.7k

All Works

Loading papers...

Rankless by CCL
2026